Pregnancy and Hypothyroidism
Pregnancy is a stress test for the thyroid, experts tell us. That is why the 1st Health Pod episode of the year is dedicated to pregnancy, as it causes significant changes to the levels of thyroid hormones (even in women without any thyroid problems), and also to the serious effects of Hypothyroidism during pregnancy. With […..]
FARAN Tops FortuneGreece List
According to the FortuneGreece‘s list of the 30 fastest-growing companies in Greece in 2022, “Looking at this year’s list, the pharmaceutical company FARAN SA is in first place in the general ranking with the third highest average rate of change in Earnings before Taxes – Interest and Depreciation – EBITDA (90.8%) and the fifth highest […..]
Infertility – Miscarriage and Hypothyroidism
In the 5th pod episode, we open the file of infertility caused by Hypothyroidism by approaching the issue both sociologically and medically. The demographic in our country tends to become a scourge. According to Eurostat data, the EU fertility rate ranks Greece in the last places, while Greek women have children at a fairly old […..]
Congenital Hypothyroidism
The 4th episode of the hit podcast, “Health Pod, Let’s Be Aware”, on Congenital Hypothyroidism (neonatal) has been uploaded to the top 3 most popular platforms. Despite the Pandemic, we continue our travels. This time, we travel in the uncharted – for many – waters of Congenital Hypothyroidism, which is the most frequent cause of […..]
Interview of Faran President
The historic pharmaceutical company FARAN is one of the fastest growing companies in the industry, recording an impressive increase in turnover, as Marios Katsikas, President & CEO of FARAN, tells us, answering the first question about the company’s course: In 2022, we are running with a 30% increase, which is impressive, but it becomes even […..]
Menopause and Hypothyroidism
The 3rd episode of the hit podcast, “Health Pod, Let’s Be Aware” on Menopause and Hypothyroidism has been uploaded to all platforms. In this episode, we dive into the bottom of the infinite female existence and come face to face with the monster of Menopause and Hypothyroidism. What happens when they coexist? How much does […..]
Faran S.A. and Quantum Genomics
On June 30, 2021, the Greek pharmaceutical company Faran has proceeded to an exclusive collaboration with the biopharmaceutical company Quantum Genomics, for the development and distribution of the innovative pharmaceutical product Firibastat for the treatment of resistant hypertension and heart failure. This is a significant investment by Faran in the research and development of an […..]
Faran S.A. and STADA Arzneimittel AG
FARAN S.A. and STADA Arzneimittel AG, are pleased to announce the beginning of their cooperation in the field of Osteoporosis. More specifically, in the context of the cooperation with STADA Arzneimittel AG, FARAN undertakes the promotion and distribution in Greek market of Movymia, STADA’s first first bio-similar Teriparatide. Movymia is indicated for the treatment of […..]
Faran S.A. and Atnhas
Faran S.A. is pleased to announce its cooperation with the pharmaceutical company Atnhas in the field of Osteoporosis, which concerns the original pharmaceutical product Bonviva (Ibandronic Acid). Bonviva is used to treat osteoporosis (a disease that makes bones brittle) in postmenopausal women at risk of fractures. Ibandronic acid is a bisphosphonate with high activity, belonging […..]
Faran S.A. and Meiji
Faran S.A. is pleased to announce its collaboration with the Japanese pharmaceutical company MEIJI in the field of infections, which concerns the launch in the Greek market of the original pharmaceutical product Spectracef (Ceftidoren Pivoxil). Spectracef (Ceftidoren Pivoxil) is a 3rd generation oral cephalosporin, a research product of the company MEIJI for the treatment of […..]